The forecasted data for Neoplasms (cancer) mortality in the US from 2024 to 2028 shows a consistent annual increase in deaths, starting from 626.06 thousand in 2024 to 633.27 thousand in 2028. This represents a year-on-year growth, highlighting a gradual but steady upward trend in mortality rates due to neoplasms. The Compound Annual Growth Rate (CAGR) for this period indicates an average annual increase, underscoring a concerning trend in cancer mortality.
Looking ahead, it is crucial to monitor advancements in medical technology, cancer treatment innovations, and public health initiatives aimed at cancer prevention and early detection. These factors could significantly influence future mortality trends for neoplasms in the US.
